Clinical Trial Update: Clinical and Immunohisochemical Evaluation of Chemopreventive Effect of Thymoquinone on Oral Potentially Malignant Lesions. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the chemopreventive effect of thymoquinone on oral premalignant lesions with immunohistochemical assessment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premalignant Lesion of the Oral Cavity

Drugs mentioned

• Thymoquinone (thymoquinone)

Snippet

Sponsor: Cairo University | Conditions: Premalignant Lesion | Phase 2 | Status: COMPLETED